Tharimmune, Inc. (THAR)
2.41
+0.01
(+0.42%)
USD |
NASDAQ |
Dec 16, 16:00
2.38
-0.03
(-1.24%)
After-Hours: 20:00
Tharimmune Research and Development Expense (Annual): 6.392M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Phio Pharmaceuticals Corp. | 3.643M |
| ETHZilla Corp. | 1.969M |
| Flora Growth Corp. | 0.418M |
| NovaBay Pharmaceuticals, Inc. | 0.042M |
| Palatin Technologies, Inc. | 14.90M |